Solifenacin/Tamsulosin (Vesomni®)
Indication
Treatment of Storage Symptoms associated with Benign Prostatic Hyperplasia
*FOR FYLDE & WYRE CCG ONLY* - For use in men who were already taking tamsulosin with some response; however the response was not adequate.
*FOR MORECAMBE BAY CCG ONLY* - Not to be used as first line
Green
Brand:
Vesomni®
Nice TA:
Commissioning responsibility:
CCG
PbR excluded:
No
BNF chapter:
Genito-urinary system
Background
Vesomni® one tablet daily is recommended for the treatment of moderate to severe storage symptoms (urgency, increased micturition frequency) and voiding symptoms associated with benign prostatic hyperplasia in men who are not adequately responding to treatment with tamsulosin monotherapy.
Recommendation
LSCMMG Recommendation:
Green
Reason for decision:
Suitable for initiation in primary care
Supporting documents: